According to the news organisation FIS, the Centrovet laboratory undertook two years of research in full compliance of international standards and invested around USD 6 million in developing the vaccine from a viral strain present in salmon from the south of Chile; the company hopes to produce 60 million doses this year.
FIS says that the vaccine has been very well received by clients "who very much hope the vaccine will solve the problems currently being faced by the industry," assured David Farcas, general manager of Centrovet.
According to the laboratory manager, the vaccine is the first immunological alternative of its kind developed in Chile to combat the ISA virus, a pathogen that has disrupted Chile's salmon farming industry since mid-2007.
Chile Approves ISA Vaccine
CHILE - The Ministry of Agriculture, through the Secretariat of Agriculture and Livestock (SAG), last week approved an infectious salmon anaemia (ISA) vaccine developed by a domestic veterinary pharmaceutical company. Sales of the vaccine will begin in June.
